Charles River Laboratories International (CRL) Other Accumulated Expenses (2009 - 2025)

Charles River Laboratories International's Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $222.2 million for Q4 2025.

• In Q4 2025, Other Accumulated Expenses rose 14.51% year-over-year to $222.2 million; the TTM figure through Dec 2025 stood at $222.2 million (up 14.51% YoY), while the FY2025 annual figure was $222.2 million, up 14.51% from the prior year.
• Other Accumulated Expenses was $222.2 million for Q4 2025 at Charles River Laboratories International, up from $216.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $222.2 million in Q4 2025 to a low of $97.3 million in Q1 2021.
• Historically, Other Accumulated Expenses has averaged $184.3 million across 5 years, with a median of $196.2 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses declined 10.63% in 2021, then soared 48.47% in 2022.
• A 5-year view of Other Accumulated Expenses shows it stood at $140.4 million in 2021, then jumped by 45.67% to $204.6 million in 2022, then fell by 0.67% to $203.2 million in 2023, then slipped by 4.53% to $194.0 million in 2024, then advanced by 14.51% to $222.2 million in 2025.
• The last three Other Accumulated Expenses figures came in at $222.2 million (Q4 2025), $216.0 million (Q3 2025), and $207.2 million (Q2 2025), per Business Quant data.